Wells Fargo Initiates Coverage On Korsana Biosciences with Overweight Rating, Announces Price Target of $44
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsInitiationPrice Target
Wells Fargo analyst Benjamin Burnett initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Overweight rating and announces Price Target of $44.
Wells Fargo analyst Benjamin Burnett initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Overweight rating and announces Price Target of $44.